Therefore, we propose that β-Lap could be used as an effective chemotherapeutic agent for various OxPt-R-related cancer treatments, especially in the presence of upregulated p53 and other OxPt-R-related proteins during long-term chemotherapy. Here, TP53 is linked to cancer.